Yunnan Baiyao Group Co.,Ltd
000538.SZ · SHZ
Market closed51.42-0.690000 (-1.32%)
Key statistics
Previous close52.11
Open50.82
Day high52.62
Day low50.82
52-week high60.69
52-week low46.29
Market cap91.75B
Volume13.54M
Average volume9.71M
P/E ratio15.38
Forward P/E—
EPS3.34
Dividend yield+5.06%
Market context
Why it moved
000538.SZ (Yunnan Baiyao) edged lower amid broad sector rotation out of healthcare stocks into financials and technology, as shifting market sentiment and profit-taking pressure weighed on the share price.
What is happening
Recent company-specific developments and publisher coverage.
AD HOC NEWS · July 4, 2026Yunnan Baiyao Group highlights traditional Chinese medicine roots as a diversified healthcare playerfinance.biggo.com · April 2, 2026Yunnan Baiyao's 2025 Net Profit Rises Over 8%, Bets on Nuclear Medicine for Second Growth CurveSouth China Morning Post · October 27, 2018Toothpaste lawsuit sparks debate over traditional medicineSixth Tone · October 23, 2018Herbal Chinese Toothpaste Brand Accused of Using Western Drugs Mt Newswire · June 4, 2026Yunnan Baiyao Secures US FDA Approval for Metabolic Disorder Drug Mt Newswire · April 2, 2026Yunnan Baiyao Gets Nod to Trial INB301 Injection Mt Newswire · April 1, 2026Yunnan Baiyao's Attributable Profit Jumps 8.5% in 2025 Mt Newswire · February 11, 2026Baiyao Names Chief Scientist Mt Newswire · October 31, 2025Yunnan Baiyao's Attributable Profit Increases Marginally in Q3